TY - JOUR
T1 - Hip protectors: recommendations for biomechanical testing-an international consensus statement (part I)
AU - Robinovitch, S.N.
AU - Evans, S.L.
AU - Minns, J.
AU - Laing, A.C.
AU - Kannus, P.
AU - Cripton, P.A.
AU - Derler, S.
AU - Birge, S.J.
AU - Plant, D.
AU - Cameron, I.D.
AU - Kiel, D.P.
AU - Howland, J.
AU - Khan, K.
AU - Lauritzen, Jes Bruun
N1 - Times Cited: 1ArticleEnglishRobinovitch, S. NSimon Fraser Univ, Sch Engn Sci, Vancouver, BC, CanadaCited References Count: 51519UTSPRINGER LONDON LTDASHBOURNE HOUSE, THE GUILDWAY, OLD PORTSMOUTH ROAD, ARTINGTON GU3 1LP, GUILDFORD, ENGLANDARTINGTON
PY - 2009
Y1 - 2009
N2 - Hip protectors represent a promising strategy for preventing fall-related hip fractures. However, clinical trials have yielded conflicting results due, in part, to lack of agreement on techniques for measuring and optimizing the biomechanical performance of hip protectors as a prerequisite to clinical trials. In November 2007, the International Hip Protector Research Group met in Copenhagen to address barriers to the clinical effectiveness of hip protectors. This paper represents an evidence-based consensus statement from the group on recommended methods for evaluating the biomechanical performance of hip protectors. The primary outcome of testing should be the percent reduction (compared with the unpadded condition) in peak value of the axial compressive force applied to the femoral neck during a simulated fall on the greater trochanter. To provide reasonable results, the test system should accurately simulate the pelvic anatomy, and the impact velocity (3.4 m/s), pelvic stiffness (acceptable range: 39-55 kN/m), and effective mass of the body (acceptable range: 22-33 kg) during impact. Given the current lack of clear evidence regarding the clinical efficacy of specific hip protectors, the primary value of biomechanical testing at present is to compare the protective value of different products, as opposed to rejecting or accepting specific devices for market use
Udgivelsesdato: 2009/12
AB - Hip protectors represent a promising strategy for preventing fall-related hip fractures. However, clinical trials have yielded conflicting results due, in part, to lack of agreement on techniques for measuring and optimizing the biomechanical performance of hip protectors as a prerequisite to clinical trials. In November 2007, the International Hip Protector Research Group met in Copenhagen to address barriers to the clinical effectiveness of hip protectors. This paper represents an evidence-based consensus statement from the group on recommended methods for evaluating the biomechanical performance of hip protectors. The primary outcome of testing should be the percent reduction (compared with the unpadded condition) in peak value of the axial compressive force applied to the femoral neck during a simulated fall on the greater trochanter. To provide reasonable results, the test system should accurately simulate the pelvic anatomy, and the impact velocity (3.4 m/s), pelvic stiffness (acceptable range: 39-55 kN/m), and effective mass of the body (acceptable range: 22-33 kg) during impact. Given the current lack of clear evidence regarding the clinical efficacy of specific hip protectors, the primary value of biomechanical testing at present is to compare the protective value of different products, as opposed to rejecting or accepting specific devices for market use
Udgivelsesdato: 2009/12
M3 - Journal article
SN - 0937-941X
VL - 20
SP - 1977
EP - 1988
JO - Osteoporosis International
JF - Osteoporosis International
IS - 12
ER -